Javier Rojo Selected Research

DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)

5/2021	Glycodendritic structures as DC-SIGN binders to inhibit viral infections.
1/2019	Synthesis of Highly Efficient Multivalent Disaccharide/[60]Fullerene Nanoballs for Emergent Viruses.
1/2018	Nanocarbon-Based Glycoconjugates as Multivalent Inhibitors of Ebola Virus Infection.
8/2017	Antiviral activity of self-assembled glycodendro[60]fullerene monoadducts.
8/2015	Investigation of glycofullerene dynamics by NMR spectroscopy.
4/2014	A multivalent inhibitor of the DC-SIGN dependent uptake of HIV-1 and Dengue virus.
2/2013	Structure of a glycomimetic ligand in the carbohydrate recognition domain of C-type lectin DC-SIGN. Structural requirements for selectivity and ligand design.
2/2013	Glycofullerenes inhibit viral infection.
1/2012	A glycomimetic compound inhibits DC-SIGN-mediated HIV infection in cellular and cervical explant models.
8/2011	Second generation of fucose-based DC-SIGN ligands: affinity improvement and specificity versus Langerin.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Javier Rojo Research Topics

Disease

20	Infections 01/2022 - 12/2003
5	Food Hypersensitivity (Food Allergy) 07/2022 - 01/2017
5	Virus Diseases (Viral Diseases) 05/2021 - 07/2011
5	HIV Infections (HIV Infection) 02/2013 - 03/2010
4	Anaphylaxis (Anaphylactic Shock) 01/2022 - 01/2017
4	Hypersensitivity (Allergy) 11/2021 - 11/2019
2	Ebola Hemorrhagic Fever 01/2018 - 12/2003
2	Apraxias (Dyspraxia) 06/2014 - 10/2012
2	Neoplasms (Cancer) 11/2010 - 03/2004
1	Rosacea (Acne Rosacea) 07/2022
1	Seasonal Allergic Rhinitis (Hay Fever) 01/2020
1	type 2C Congenital disorder of glycosylation 01/2020
1	Dengue (Dengue Fever) 04/2014
1	Melanoma (Melanoma, Malignant) 01/2014
1	Brain Ischemia (Cerebral Ischemia) 09/2012
1	Brain Injuries (Brain Injury) 09/2012
1	Chronic Obstructive Pulmonary Disease (COPD) 03/2011
1	Communicable Diseases (Infectious Diseases) 05/2006
1	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 07/2005
1	Neoplasm Metastasis (Metastasis) 03/2004

Drug/Important Bio-Agent (IBA)

18	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 05/2021 - 12/2003
8	CarbohydratesIBA 05/2021 - 07/2007
7	LigandsIBA 11/2021 - 05/2007
6	Antiviral Agents (Antivirals)IBA 05/2021 - 07/2007
5	C-Type Lectins (C-Type Lectin)IBA 01/2022 - 05/2006
5	Dendrimers (Dendrons)IBA 01/2020 - 09/2004
4	AntigensIBA 01/2022 - 01/2014
4	Peptides (Polypeptides)IBA 11/2021 - 10/2019
4	GlycoconjugatesIBA 01/2019 - 05/2007
4	LectinsIBA 02/2013 - 05/2007
3	AllergensIBA 01/2022 - 01/2020
3	Mannose (D-Mannose)IBA 11/2019 - 09/2004
3	Glycoproteins (Glycoprotein)IBA 08/2017 - 03/2004
2	Proteins (Proteins, Gene)FDA Link 07/2022 - 01/2012
2	VaccinesIBA 01/2020 - 11/2010
2	Biological ProductsIBA 01/2019 - 02/2013
2	dendronIBA 01/2012 - 03/2010
2	IntegrinsIBA 03/2010 - 05/2006
2	DisaccharidesIBA 07/2007 - 07/2005
1	LipidsIBA 07/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2021
1	lipid transfer protein (glycolipid transfer protein)IBA 11/2021
1	indoleIBA 11/2021
1	Pru p 3 allergenIBA 11/2021
1	Toll-Like Receptor AgonistsIBA 11/2021
1	8-hydroxyadenineIBA 11/2021
1	Carrier Proteins (Binding Protein)IBA 11/2021
1	Immunoglobulin E (IgE)IBA 11/2021
1	Immunodominant EpitopesIBA 01/2020
1	SugarsIBA 01/2017
1	LipopolysaccharidesIBA 01/2017
1	FullerenesIBA 01/2017
1	Alkynes (Acetylenes)IBA 01/2017
1	CarbonIBA 01/2017
1	Pharmaceutical PreparationsIBA 06/2014
1	Complement System Proteins (Complement)IBA 09/2012
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 09/2012
1	Cell Adhesion MoleculesIBA 01/2012
1	ChemokinesIBA 01/2012
1	Polysaccharides (Glycans)IBA 01/2012
1	PolyestersIBA 07/2011
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2011
1	Biomarkers (Surrogate Marker)IBA 03/2011
1	Anti-Infective Agents (Microbicides)IBA 07/2010
1	Intercellular Adhesion Molecule-3IBA 03/2010
1	MaltoseIBA 07/2005
1	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA 03/2004
1	GlycosphingolipidsIBA 03/2004
1	Lactose FDA LinkGeneric 03/2004
1	BH30sucManIBA 12/2003

Therapy/Procedure

5	Immunotherapy 01/2022 - 01/2017
1	Activities of Daily Living (ADL) 06/2014
1	Cognitive Training 10/2012
1	Therapeutics 07/2010